Loading...
XTAI
4104
Market cap467mUSD
Jul 28, Last price  
84.10TWD
1D
-0.24%
1Q
-2.66%
Jan 2017
117.99%
IPO
62.83%
Name

Excelsior Medical Co Ltd

Chart & Performance

D1W1MN
XTAI:4104 chart
No data to show
P/E
17.82
P/S
1.61
EPS
4.72
Div Yield, %
4.51%
Shrs. gr., 5y
2.88%
Rev. gr., 5y
5.75%
Revenues
8.54b
+3.71%
14,300,782,00015,355,606,0005,994,336,0005,998,988,0005,740,961,0005,806,677,0006,202,884,0006,205,758,0006,095,337,0006,345,031,0006,457,362,0006,675,494,0006,573,152,0007,186,828,0008,233,404,0008,538,546,000
Net income
771m
+3.30%
311,950,000355,692,000333,970,000275,785,000299,942,000285,681,000379,000,000389,557,000399,047,000451,562,000514,755,000571,670,000607,149,000667,453,000746,605,000771,259,000
CFO
2.47b
+2,207.58%
693,512,000-33,458,000-528,524,000717,257,000357,477,000736,736,000739,959,000449,713,000-487,388,000192,434,0001,194,496,000869,433,000945,049,000637,126,000107,101,0002,471,445,000
Dividend
Apr 19, 20243.8 TWD/sh

Profile

Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.
URL
https://www.excelsiormedical.com.tw/
IPO date
Jun 08, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,538,546
3.71%
8,233,404
14.56%
7,186,828
9.34%
Cost of revenue
7,788,879
7,537,275
6,566,075
Unusual Expense (Income)
NOPBT
749,667
696,129
620,753
NOPBT Margin
8.78%
8.45%
8.64%
Operating Taxes
203,307
221,230
178,399
Tax Rate
27.12%
31.78%
28.74%
NOPAT
546,360
474,899
442,354
Net income
771,259
3.30%
746,605
11.86%
667,453
9.93%
Dividends
(591,344)
(540,953)
(494,021)
Dividend yield
4.20%
4.11%
5.15%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,047,805
1,204,853
626,401
Long-term debt
883,997
543,624
454,968
Deferred revenue
Other long-term liabilities
21,674
16,308
17,297
Net debt
(7,164,836)
(7,734,578)
(5,961,534)
Cash flow
Cash from operating activities
2,471,445
107,101
637,126
CAPEX
(114,866)
(142,637)
(172,505)
Cash from investing activities
(65,567)
(158,457)
(690,005)
Cash from financing activities
(955,956)
(104,512)
(633,889)
FCF
2,418,512
(349,702)
288,046
Balance
Cash
5,048,140
3,406,068
3,228,613
Long term investments
4,048,498
6,076,987
3,814,290
Excess cash
8,669,711
9,071,385
6,683,562
Stockholders' equity
7,641,077
6,999,476
9,182,254
Invested Capital
5,163,582
5,371,473
4,341,060
ROIC
10.37%
9.78%
10.41%
ROCE
5.71%
5.52%
5.51%
EV
Common stock shares outstanding
163,727
156,262
156,406
Price
86.00
2.15%
84.19
37.30%
61.32
23.23%
Market cap
14,080,553
7.03%
13,155,698
37.17%
9,590,809
23.16%
EV
9,302,829
7,721,070
5,726,152
EBITDA
1,050,499
961,805
843,191
EV/EBITDA
8.86
8.03
6.79
Interest
27,116
17,197
10,449
Interest/NOPBT
3.62%
2.47%
1.68%